๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Highlights: Volume 226, Number 7


Book ID
102313100
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
297 KB
Volume
226
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

โœฆ Synopsis


In a mini-review, Sundeep Kalantry describes new findings and outstanding questions in the field of X-chromosome inactivation -a paradigm of epigenetic inheritance. X-inactivation results in the mitotically-stable transcriptional silencing of genes along one of the two X-chromosomes in female mammals. How the cell distinguishes two identical chromosomal sequences to trigger inactivation of one X-chromosome while sparing the other and what the mechanisms are that propagate epigenetic inactivation as well as its prevention are among the major questions about X-inactivation that have long fascinated biologists. X-linked non-coding RNAs such as Xist and Tsix along with proteins of the Polycomb group play an essential role during X-inactivation. However, the precise contribution of these factors to the execution of the epigenetic states of the inactive-and the active-X remains unclear. Recent work indicates a finely-tuned requirement of these factors during X-inactivation, and posits that there likely are other factors that work in concert with these during X-inactivation. That X-inactivation only occurs in XX female cells and not in XY male cells is another challenging quest that has vexed X-inactivation enthusiasts. Quite intriguingly, recent developments suggest a role for the X-linked Rnf12 gene in the counting of the number of X-chromosomes -only when a certain threshold of RNF12 protein is reached, will X-inactivation be triggered. X-inactivation promises to continue to yield insights into fundamental epigenetic processes.


๐Ÿ“œ SIMILAR VOLUMES


Highlights: Volume 226, Number 12
๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB

A controversial aspect of adult-derived stem cells is whether they have the ability to stably transdifferentiate ("dedifferentiate-redifferentiate") into neural cell types. Spitzer et al. have demonstrated that PBD-MAPCs, novel stem cells derived from blood, have high capacity in vitro to stably dif